Brightside vs Cerebral: Anxiety and Depression Care Compared

—————————————————————-

Brightside Health and Cerebral both offer integrated psychiatric care — medication management plus optional therapy through a single platform. They are often considered alongside each other by people seeking online treatment for depression, anxiety, or related conditions. The two platforms differ in clinical infrastructure, outcome measurement, regulatory history, and reputation. This brightside vs cerebral comparison breaks down 2026 pricing, what each platform offers, the regulatory events that have shaped both, and which may fit which needs. In short: Brightside publishes more outcome data and offers a structured crisis program, while Cerebral is comparably priced but carries a more complicated regulatory history. This is a general, non-clinical overview to help you ask better questions, not a substitute for advice from a licensed clinician.

If you are in crisis, get help now. If you or someone you know is thinking about suicide or is in emotional distress, call or text 988 to reach the 988 Suicide & Crisis Lifeline (available 24/7 in the US), or chat at 988lifeline.org. If there is an immediate danger to life, call 911 or go to the nearest emergency room. Online psychiatry platforms are not emergency services and should not be relied on during a crisis.

Brightside vs Cerebral — pricing in 2026

The figures below reflect advertised cash pricing as of 2026; plans, prices, and insurance networks change, so confirm current details on each platform’s site before enrolling.

Brightside Health pricing (as advertised):

• Medication-only plan: about $95/month + medication cost
• Therapy-only plan: about $299/month for four 45-minute sessions
• Therapy + Medication combined: about $349/month
• Crisis Care plan (for elevated risk, including some suicidality): about $349/month
• Insurance accepted: reported to include Aetna, BCBS, Cigna, Optum, UnitedHealthcare, and regional plans

Cerebral pricing (as advertised):

• Medication management plan: about $99/month + medication cost
• Therapy-only plan: about $295/month for four sessions
• Medication + therapy combined: about $325/month
• Insurance accepted: reported to include Aetna, Cigna, Anthem, and select regional plans

Pricing is broadly comparable at the cash-pay level. Brightside has generally accepted more insurance plans than Cerebral, which can produce lower in-network costs for many patients, but coverage varies by state and plan year. See our individual Brightside Health review and Cerebral review, and our broader telehealth guide for context.

Clinical infrastructure

Brightside markets a more structured clinical model than Cerebral, with three commonly cited differences:

Algorithmic medication support. Brightside uses a decision-support tool (marketed as PrecisionRx) intended to help clinicians select medications based on patient symptoms, prior treatment history, and side-effect profiles. It is a support tool for prescribers, not a replacement for clinical judgment, and any medication decision is ultimately made by the treating clinician with you.

Structured outcome measurement. Brightside uses PHQ-9 (depression) and GAD-7 (anxiety) symptom scales at visits and tracks outcomes over time. The company has published peer-reviewed outcome data reporting depression and anxiety improvement rates; as with any company-associated research, results should be read with that context in mind. Cerebral also does some outcome tracking but has less published peer-reviewed outcome research.

Crisis Care program. Brightside’s Crisis Care program is designed to serve patients at elevated risk through more frequent visits, safety planning, and escalation protocols. Many direct-to-consumer mental health platforms exclude higher-risk patients entirely, so this is a meaningful structural difference — though it is not a substitute for emergency care or the 988 Lifeline in an acute crisis.

Regulatory and reputational history

Cerebral’s regulatory history is one of the most important factors for many prospective patients, and it is worth stating accurately rather than in shorthand.

In 2022, Cerebral drew scrutiny from the Drug Enforcement Administration and reporting about its prescribing of controlled substances, particularly ADHD stimulants such as Adderall. The company stopped prescribing controlled substances to all patients in October 2022.

In April 2024, the Federal Trade Commission and Department of Justice announced a settlement over data-privacy and cancellation practices. Regulators found Cerebral had shared the sensitive health information of roughly 3.2 million consumers with third parties and had made cancellation difficult. The order required Cerebral to pay about $7 million (including roughly $5.1 million for consumer refunds), barred it from using or disclosing sensitive health data for most advertising without consent, and mandated a simpler cancellation process.

In November 2024, Cerebral reached a separate settlement with the DOJ over its earlier controlled-substance prescribing, agreeing to pay about $3.6 million, according to Healthcare Dive. As part of that agreement, Cerebral confirmed it had stopped prescribing controlled substances and agreed not to prescribe them in the future.

In 2025 and 2026, Cerebral moved to re-enter ADHD care through acquisitions — including a behavior-focused ADHD app in early 2026, per Behavioral Health Business — but this reentry has centered on non-medication support rather than stimulant prescribing, and Cerebral has remained under its commitment not to prescribe controlled substances. By contrast, Brightside does not have an equivalent regulatory or reputational history and has run a more conservative clinical model from the start.

Therapy integration

Both platforms offer integrated therapy and medication in their combined plans. Brightside describes tighter integration, with therapists and prescribers coordinating through shared notes, so its Therapy + Medication plan aims to be genuinely coordinated rather than two parallel services.

Cerebral’s combined plan also pairs therapy and medication, though its therapy network and clinical infrastructure are generally described as less developed. For patients who want both modalities through a single platform, both can work; the practical question is how well the two providers coordinate, which varies by clinician and by patient.

What both platforms treat

Both platforms handle the core psychiatric medication conditions: depression, anxiety, panic disorder, insomnia, OCD, and certain mood disorders. The standard formulary at both includes SSRIs, SNRIs, some mood stabilizers, non-controlled anti-anxiety medications, and other non-controlled psychiatric medications.

For people with typical depression or anxiety presentations, both platforms can support good outcomes when patients engage consistently and work closely with their clinician. Any difference in results is likely to come down to the quality and consistency of the individual clinical relationship as much as the platform’s tooling.

What both platforms don’t treat well

Both platforms share important limitations:

• Schedule II controlled-substance prescribing for ADHD is not offered; new stimulant starts generally require an in-person visit under current DEA telemedicine rules, and Cerebral specifically has agreed not to prescribe controlled substances
• Severe psychiatric conditions including active psychosis, severe eating disorders requiring medical monitoring, and acute mania are outside both platforms’ scope
• Substance use disorder treatment is not a primary focus for either platform
• Comorbid medical conditions that require coordination with primary care need separate medical management

For patients with these conditions, in-person psychiatric care is generally more appropriate. For ADHD specifically, since neither platform prescribes stimulants, a different care pathway is needed.

When each platform may fit

Brightside may fit if: you want a structured online psychiatric model with measurement-based care and published outcome data; you are managing depression or anxiety; you may benefit from the Crisis Care program; or your insurance covers Brightside (often broader acceptance than Cerebral).

Cerebral may fit if: your insurance specifically covers Cerebral but not Brightside; you have had a positive prior experience with Cerebral; or its plan pricing works better for your situation.

Neither may fit if: you need traditional in-person psychiatry, you are seeking ADHD stimulant prescribing, or you are managing severe psychiatric conditions outside direct-to-consumer platform scope. In any of these cases, ask a primary care clinician or local psychiatrist for a referral.

Frequently Asked Questions

Is Brightside better than Cerebral?

For non-ADHD psychiatric care, Brightside markets a more structured clinical model and has more published outcome data, and it does not carry Cerebral’s regulatory history. “Better” still depends on your specific needs, insurance, and the individual clinician you work with, so treat this as a general comparison rather than a verdict for every person.

Which is cheaper?

Advertised cash pricing is broadly similar. For insured patients, Brightside’s broader insurance acceptance often produces lower in-network costs, but this varies by plan and state. Verify current pricing and coverage on each platform before enrolling.

Which has better clinicians?

Both use licensed psychiatric clinicians (physicians, nurse practitioners, and therapists). Clinical quality varies by individual provider at both platforms, so a specific clinician match matters more than the brand.

Does either prescribe controlled substances for ADHD?

No. Neither platform prescribes Schedule II ADHD stimulants. Cerebral stopped prescribing controlled substances in 2022 and, as part of a 2024 DOJ settlement, agreed not to prescribe them in the future. Brightside generally does not prescribe Schedule II ADHD stimulants either. If you need stimulant treatment, you will need a different provider, often with an in-person evaluation.

Can I switch from one to the other?

Yes. Some patients move between platforms based on insurance changes or personal preference. Records can typically be transferred with your consent, and it is wise to avoid a gap in any ongoing medication when switching — coordinate the transition with a clinician.

The bottom line on Brightside vs Cerebral

Both Brightside Health and Cerebral provide online psychiatric care for depression and anxiety, and both can work well for people who engage consistently with their clinician. Brightside offers a more structured, measurement-based model with published outcome data and a Crisis Care program, and it does not carry Cerebral’s regulatory history — which includes 2022 DEA scrutiny, a 2024 FTC/DOJ data-privacy settlement, and a late-2024 DOJ settlement after which Cerebral agreed not to prescribe controlled substances. Advertised pricing is comparable, with Brightside typically accepting broader insurance. Cerebral remains a reasonable option for patients whose insurance covers it or who have had a good prior experience. Whichever you choose, therapy and medication decisions are clinician-directed, this article is not medical advice, and if you are ever in crisis, call or text 988.